JNM CE/SAM (July 2018): Alpha-Emitters for Radiotherapy: From Basic Radiochemistry to Clinical Studies—Part 2

JNM, July 2018, Volume 59, Number 7

Release Date: 7/1/2018
Expiration Date: 7/30/2021

SNMMI Members: Free
Non-Members: $69.00

Continuing Education Credit Information

ABNM SAM Credit
The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment. 2.0 SAMs have been awarded for this activity.

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SNMMI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Objectives
On successful completion of this activity, participants should be able to…
1. Match alpha-emitters to potential vectors or targets of interest.
2. Highlight the potential of α-emitters in preclinical work.
3. Identify the current clinical uses of α-emitters and the importance of clinical trial design for broader application of alpha-therapy


Target Audience
This article contains information of value to radiopharmacists and nuclear medicine radiologists, as well as to researchers looking to start projects with alpha-emitters.

Authors
Sophie Poty1, Lynn C. Francesconi2,3, Michael R. McDevitt1,4, Michael J. Morris5, and Jason S. Lewis1,6
1Department of Radiology and Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York; 2Department of Chemistry, Hunter College, New York, New York; 3Graduate Center of City University of New York, New York, New York; 4Department of Radiology, Weill Cornell Medical College, New York, New York; 5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and 6 Departments of Radiology and Pharmacology, Weill Cornell Medical College,New York, New York


Disclosure
This work is supported by the Radiochemistry and Molecular Imaging Probe Core, which is supported in part by NIH/NCI Cancer Center Support Grant P30 CA008748. Jason Lewis is supported by the Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research and by the Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center. Sophie Poty is supported by the François Wallace Monahan Fellowship from the JLM Benevolent Fund. In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the authors have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.

Contact Information

For questions please contact Lisa Dickinson, Associate Director of Education at ldickinson@snmmi.org or 703-652-6783.